Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$13.32 - $19.19 $579,420 - $834,765
-43,500 Reduced 96.67%
1,500 $26,000
Q1 2024

May 14, 2024

BUY
$13.02 - $21.3 $585,900 - $958,500
45,000 New
45,000 $684,000
Q3 2020

Nov 12, 2020

SELL
$18.49 - $27.24 $517,719 - $762,720
-28,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$8.9 - $21.84 $249,200 - $611,520
28,000 New
28,000 $545,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.49B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.